$12.73
-0.48 (-3.63%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+176.7% upside
Low Target
$21.76
Average Target
$35.22
High Target
$46.82
Current Price
$12.73
Current
$12.73
$12.73
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Scenario Analysis
Bear Case
$21.76
70.9%
Low target
Base Case
$35.22
+176.7%
Avg target
Bull Case
$46.82
+267.8%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$20.46
-37.8% from high
52-Week Low
$7.21
+76.6% from low
50-Day SMA
$10.21
+24.7% vs SMA
200-Day SMA
$10.82
+17.7% vs SMA
RSI (14)
63.1
Neutral
Target vs 52W High
$35.22
+72.2% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.20
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |